Expression of anti-cardiolipin antibodies and inflammatory associated factors in patients with schizophrenia.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Psychiatry Research

• Publication date

  2011-05-30

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.psychres.2010.04.049PMID 20510460
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Higher serum clozapine level is associated with increased antiphospholipid antibodies in schizophrenia patients.

  2009cited by this paper
• Development of TLR inhibitors for the treatment of autoimmune diseases

  2008cited by this paper
• Beneficial effects of treatment with cystamine on brain in NZB/W F1 mice.

  2008cited by this paper
• Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.

  2008cited by this paper
• [Role of IL-6 in the development and pathogenesis of CIA and EAE].

  2008cited by this paper
• CIA, EAEの病態形成におけるIL-6の役割

  2008cited by this paper
• Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis.

  2007cited by this paper
• Interleukin-6--a key mediator of systemic and local symptoms in rheumatoid arthritis.

  2007cited by this paper
• Association of schizophrenia and autoimmune diseases: linkage of Danish national registers.

  2006cited by this paper
• Circulating Total and Active Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinases-1 in Patients with Systemic Lupus Erythomatosus

  2006cited by this paper
• Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.

  2006cited by this paper
• Genetic variation in toll-like receptor 9 and susceptibility to systemic lupus erythematosus.

  2006cited by this paper
• Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission

  2006cited by this paper
• Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents.

  2005cited by this paper
• A stop codon polymorphism of Toll-like receptor 5 is associated with resistance to systemic lupus erythematosus.

  2005cited by this paper
• Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.

  2004cited by this paper
• Antipsychotic-Induced Venous Thromboembolism

  2002cited by this paper
• Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology.

  2002cited by this paper
• Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients.

  2001cited by this paper
• Association of venous thromboembolism and clozapine.

  2000cited by this paper
• Antipsychotic drugs and venous thromboembolism.

  2000cited by this paper
• Pathophysiologic mechanisms in the pathogenesis and clinical course of schizophrenia.

  1999cited by this paper
• Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia.

  1997cited by this paper
• Elevated circulating levels of IL-6 in schizophrenia.

  1996cited by this paper
• [Symptomatic antiphospholipid antibody after neuroleptic drugs].

  1995cited by this paper
• Increased prevalence of antibrain antibodies in the sera from schizophrenic patients.

  1994cited by this paper
• Immune Abnormalities in Schizophrenia: Evidence for the Autoimmune Hypothesis

  1994cited by this paper
• Serum antibodies to nicotinic acetylcholine receptors in schizophrenic patients.

  1994cited by this paper
• Autoantibodies to DNA in multicase families with schizophrenia.

  1993cited by this paper
• Antiphospholipid antibody syndrome.

  1992cited by this paper
• The immune system is a key factor in the etiology of psychosocial disease.

  1991cited by this paper
• Platelet Autoantibodies in Dementia and Schizophrenia

  1991cited by this paper
• Platelet autoantibodies in dementia and schizophrenia. Possible implication for mental disorders.

  1991cited by this paper
• Antiseptal brain antibody in IgG of schizophrenic patients.

  1989cited by this paper
• Increased numbers of CD5+ B lymphocytes in schizophrenic patients.

  1989cited by this paper
• Decreased interleukin-2 production in schizophrenic patients.

  1989cited by this paper
• Is schizophrenia an immunologic receptor disorder?

  1983cited by this paper
• Autoimmune model of schizophrenia with special reference to antibrain antibodies.

  1981cited by this paper
• Immunologic studies in schizophrenic and control subjects.

  1980cited by this paper

• The Correlation of Blood Immune Cells with the Pathogenesis of Schizophrenia: A Meta-Analysis

  2025cites this paper
• Monocytic TLR4 expression and activation in schizophrenia: A systematic review and meta-analysis

  2025cites this paper
• Differences in Blood Leukocyte Subpopulations in Schizophrenia: A Systematic Review and Meta-Analysis.

  2025cites this paper
• Elevated matrix Metalloproteinase-9 associated with reduced cerebellar perineuronal nets in female mice with toxoplasmosis

  2024cites this paper
• Diagnostic significance of combined anti-extractable nuclear antigens antibody, anti-cardiolipin antibody and anti-β2-glycoprotein 1 in systemic lupus erythematosus patients

  2024cites this paper
• High Prevalence of aCL-IgA and aβ2GPI-IgA in Drug-Free Schizophrenia Patients: Evidence of a Potential Autoimmune Link

  2024cites this paper
• A rare case of schizophrenia coexistence with antiphospholipid syndrome, β-thalassemia, and monoclonal gammopathy of undetermined significance

  2023cites this paper
• Toll-Like Receptor mRNA Levels in Schizophrenia: Association With Complement Factors and Cingulate Gyrus Cortical Thinning.

  2023cites this paper
• Counting the Toll of Inflammation on Schizophrenia—A Potential Role for Toll-like Receptors

  2023cites this paper
• Genome-wide Association Analysis of Schizophrenia and Vitamin D Levels Shows Shared Genetic Architecture and Identifies Novel Risk Loci

  2023cites this paper
• Toll-Like Receptor 4 Gene Polymorphisms and Susceptibility to Schizophrenia: A Case-Control Study

  2022cites this paper
• Matrix metalloproteinase-3 serum levels in schizophrenic patients

  2022cites this paper
• Schizophrenia-derived hiPSC brain microvascular endothelial-like cells show impairments in angiogenesis and blood–brain barrier function

  2022cites this paper
• Lipophilic vs. hydrophilic statins and psychiatric hospitalizations and emergency room visits in US Veterans with schizophrenia and bipolar disorder

  2021cites this paper
• Adjunctive simvastatin treatment in schizophrenia patients; a double blind randomized and placebo controlled trial

  2021cites this paper
• The association of matrix metalloproteinase 9 (MMP9) with hippocampal volume in schizophrenia: a preliminary MRI study

  2021cites this paper
• Expression and functionality study of 9 Toll-like receptors in drug-naïve non-affective first episode psychosis individuals: a 3-month study

  2020influential citation
• Systemic concentration of apelin, but not resistin or chemerin, is altered in patients with schizophrenia

  2020cites this paper
• Plasma levels of matrix metalloproteinase‐9 (MMP‐9) are associated with cognitive performance in patients with schizophrenia

  2020cites this paper
• Expression and Functionality Study of 9 Toll-Like Receptors in 33 Drug-Naïve Non-Affective First Episode Psychosis Individuals: A 3-Month Study

  2020influential citation
• Immunomodulatory effects of antipsychotic treatment on gene expression in first-episode psychosis.

  2019cites this paper
• The expression of toll-like receptors in peripheral blood mononuclear cells is altered in schizophrenia.

  2019cites this paper
• Pattern of expression of Toll like receptor (TLR)-3 and -4 genes in drug-naïve and antipsychotic treated patients diagnosed with schizophrenia.

  2019cites this paper
• MMPs in learning and memory and neuropsychiatric disorders

  2019cites this paper
• In vitro cytokine synthesis in unstimulated and mitogen-stimulated peripheral blood mononuclear cells from individuals with schizophrenia

  2019cites this paper
• Peripheral Markers of Immune Response in Major Psychiatric Disorders: Where Are We Now and Where Do We Want to Be?

  2019cites this paper
• Meta‐analysis of total and differential white blood cell counts in schizophrenia

  2019cites this paper
• Venous Thromboembolism During Treatment with Antipsychotics: A Review of Current Evidence

  2018cites this paper
• Deciphering the interplay between peripheral and central cytokine- and kynurenine pathways : importance for the pathophysiology of schizophrenia

  2018cites this paper
• The impact of antipsychotics as a risk factor for thromboembolism

  2018cites this paper
• Comparison of Serum Levels of Tumor Necrosis Factor Alpha (TNF-α) in Batak Male Schizophrenic Patients Versus Healthy Controls

  2018cites this paper
• Risk and prophylaxis of venous thromboembolism in hospitalized psychiatric patients. A review.

  2018cites this paper
• “Immune Gate” of Psychopathology—The Role of Gut Derived Immune Activation in Major Psychiatric Disorders

  2018cites this paper
• CaMKIIα expression in a mouse model of NMDAR hypofunction schizophrenia: Putative roles for IGF-1R and TLR4.

  2018cites this paper
• Lipidome alterations in human prefrontal cortex during development, aging, and cognitive disorders

  2018cites this paper
• Modification of the association between antipsychotic treatment response and childhood adversity by MMP9 gene variants in a first-episode schizophrenia cohort.

  2018cites this paper
• Inflammation in Schizophrenia: Cytokine Levels and Their Relationships to Demographic and Clinical Variables.

  2017cites this paper
• A normal genetic variation modulates synaptic MMP‐9 protein levels and the severity of schizophrenia symptoms

  2017cites this paper
• Uniting the neurodevelopmental and immunological hypotheses: Neuregulin 1 receptor ErbB and Toll-like receptor activation in first-episode schizophrenia

  2017cites this paper
• Antipsychotics influence Toll-like receptor (TLR) expression and its relationship with cognitive functions in schizophrenia.

  2017cites this paper
• Paliperidone reverts Toll‐like receptor 3 signaling pathway activation and cognitive deficits in a maternal immune activation mouse model of schizophrenia

  2017cites this paper
• Neuroinflammatory genes associated with post-traumatic stress disorder: implications for comorbidity

  2017cites this paper
• Statins and the Brain: More than Lipid Lowering Agents?

  2017cites this paper
• Serum Levels of Tumor Necrosis Factor Alpha in Chronic Schizophrenic Versus Healthy Control and Correlation with Severity of Illness

  2017cites this paper
• Anti-phospholipid syndrome associated with schizophrenia description of five patients and review of the literature

  2017cites this paper
• Prophylaxis of venous thromboembolism in physically restrained psychiatric patients

  2016cites this paper
• MMP-9 Serum Levels in Schizophrenic Patients during Treatment Augmentation with Sarcosine (Results of the PULSAR Study)

  2016cites this paper
• MMP‐9 in translation: from molecule to brain physiology, pathology, and therapy

  2016cites this paper
• Neuroinflammation and Immunity: A New Pharmacological Target in Depression.

  2016cites this paper
• Maternal immune activation epigenetically regulates expression of the serotonin transporter in the adult offspring brain

  2015cites this paper
• CTLA4 and CD28 Gene Polymorphisms with Respect to Affective Symptom Domain in Schizophrenia

  2015cites this paper
• Matrix Metalloproteinase-9 as a Novel Player in Synaptic Plasticity and Schizophrenia.

  2015cites this paper
• Schizophrenia and bipolar disorder: The road from similarities and clinical heterogeneity to neurobiological types.

  2015cites this paper
• Association between toll-like receptor 4 expression and symptoms of major depressive disorder

  2015cites this paper
• Serum TNF-α, IL-10 and IL-2 in schizophrenic patients before and after treatment with risperidone and clozapine.

  2014cites this paper
• Neural ECM proteases in learning and synaptic plasticity.

  2014cites this paper
• Lovastatin for the adjunctive treatment of schizophrenia: a preliminary randomized double-blind placebo-controlled trial.

  2014cites this paper
• Impact of different antipsychotics on cytokines and tryptophan metabolites in stimulated cultures from patients with schizophrenia.

  2013cites this paper
• The TRIPS (Toll-like receptors in immuno-inflammatory pathogenesis) Hypothesis: a novel postulate to understand schizophrenia.

  2013cites this paper
• Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects.

  2013cites this paper
• Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine.

  2013cites this paper
• The Role of Thiamine in Schizophrenia

  2013cites this paper
• Impaired monocyte activation in schizophrenia.

  2012cites this paper
• Mmp-9 inhibitors in the brain: can old bullets shoot new targets?

  2012cites this paper
• Complement C1q formation of immune complexes with milk caseins and wheat glutens in schizophrenia.

  2012cites this paper
• Early childhood infections and risk of schizophrenia.

  2012cites this paper
• Schizophrenia and the immune system: pathophysiology, prevention, and treatment.

  2012cites this paper
• Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study.

  2012cites this paper
• Monocytic HLA DR antigens in schizophrenic patients.

  2012cites this paper
• Increased interleukin-6 and tumor necrosis factor alpha in first episode schizophrenia patients versus healthy controls.

  2012cites this paper
• Cytokines in schizophrenia: Possible role of anti‐inflammatory medications in clinical and preclinical stages

  2012cites this paper
• Spectrum of Autoantibodies in Tunisian Psychiatric Inpatients

  2012cites this paper
• Urinary Tract Infections in Psychiatric Patients

  2011cites this paper